Set realistic goals and be ready to adjust your diet and exercise
BPC-157 appears on the WADA Prohibited List under the S0 Non-Approved Substances category
Curr Pharmacol Rep 8(1):119
Liraglutide (Saxenda): The Original Weight Loss GLP-1 Liraglutide was the first GLP-1 receptor agonist to receive FDA approval specifically for chronic weight management, doing so in 2014 under the brand name Saxenda
The difference lies in clinical depth: a board-certified obesity medicine physician understands the complex interplay between metabolic hormones, body composition, pharmacokinetics, nutritional science, and behavioral psychology
Diet-induced obese (DIO) male rats were treated with (1) vehicle with ad libitum feeding (V), (2) CagriSema with ad libitum feeding (CS), (3) vehicle with pair-feeding matched to the caloric intake of the CS rats (PF) or (4) vehicle with caloric restriction to match the weight of the CS rats (weight matched (WM)) (Fig